Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amarin Releases Q3 Results: What You Need To Know
Seeking Alpha
Monday, November 12, 2012 - 11:27am
tags:
earnings, Amarin
2 Risks Facing Merck Today
Motley Fool
Monday, November 12, 2012 - 11:26am
tags:
Merck, Vioxx, Azasite, Cancidas, Nasonex, Nexium, Noxafil, Vytorin, Zetia, Emend, generics
Sarepta climbs after analyst says competitor delay removes overhang
Yahoo/Fly on the Wall
Monday, November 12, 2012 - 11:25am
tags:
Sarepta, DispersinB, GSK, Prosensa, Duchenne Muscular Dystrophy, eteplirsen
Gilead Climbs on Study Results of Hepatitis C Combo
Bloomberg
Monday, November 12, 2012 - 11:02am
tags:
Gilead, hepatitis C, sofosbuvir, GS-5885, GS-7977
Celgene Rises as Abraxane Meets Pancreatic Cancer Goals
Bloomberg
Monday, November 12, 2012 - 10:57am
tags:
Celgene, pancreatic cancer, Abraxane
Clovis halts development of cancer drug, shares plunge
Reuters
Monday, November 12, 2012 - 10:56am
tags:
Clovis Oncology, Celgene, CO-101
Novartis Starts To Climb Out Of Manufacturing Hole
Pharmalot
Monday, November 12, 2012 - 10:55am
tags:
drug manufacturing, Novartis
UK Glaxo Employee Blows Whistle On Drug Promotions
Pharmalot
Monday, November 12, 2012 - 10:53am
tags:
UK, GSK, whistleblower lawsuits, Revolade, off-label
Pfizer: Overvalued At Current Price Levels
Seeking Alpha
Monday, November 12, 2012 - 10:50am
tags:
Pfizer
Survey Of The Pancreatic Cancer Drug Market With Celgene's Abraxane In Focus
Seeking Alpha
Sunday, November 11, 2012 - 9:56am
tags:
pancreatic cancer, Celgene, Abraxane
Biotech Weekend Recap: Important Developments And Big Releases
Seeking Alpha
Sunday, November 11, 2012 - 9:49am
tags:
Amarin, Vivus, Dendreon, Arena Pharmaceuticals, Pharmacyclics, Biomarin
Jazz Pharma Earnings: A Mixed Picture
Wall St Cheat Street
Sunday, November 11, 2012 - 9:47am
tags:
Jazz Pharmaceuticals
Mylan Announces Ortho Tri-Cyclen LO® Settlement Agreement
Melodika
Sunday, November 11, 2012 - 9:45am
tags:
Mylan, Ortho Tri-cyclen, lawsuits, generics
Horizon Pharma Presents Clinical Data Demonstrating RAYOS(R) (prednisone) Delayed-Release Tablets Reduce Fatigue in Patients With Active Rheumatoid Arthritis
Yahoo/MarketWire
Sunday, November 11, 2012 - 9:34am
tags:
Horizon Therapeutics, Rayos, rheumatoid arthritis
Is This Pharma Stock Worth Buying Now?
Motley Fool
Sunday, November 11, 2012 - 9:32am
tags:
Perrigo
Amarin Still Playing the Dating Game
Motley Fool
Sunday, November 11, 2012 - 9:31am
tags:
Amarin, Vascepa
Pfizer Loses Its Cash Cow!
Motley Fool
Sunday, November 11, 2012 - 9:28am
tags:
Pfizer, Lipitor
Is It Pfizer Now That's Dodging Tax In The UK?
Forbes
Sunday, November 11, 2012 - 9:25am
tags:
Pfizer
Abbott Presents Promising Phase 2b Interferon-free Hepatitis C Results at 2012 Liver Meeting®
Yahoo/PR NewsWire
Sunday, November 11, 2012 - 9:24am
tags:
Abbott Laboratories, hepatitis C
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sunday, November 11, 2012 - 9:21am
tags:
Vivus, Orexigen, OraSure

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.